Table 1.
Study group and Reference number | GA (weeks) | BW (gram) | Gender | AD (days) | Comorbidity | Symptoms | IC | CF | Outcome |
---|---|---|---|---|---|---|---|---|---|
This study | FT | 2900 | M | 4 | PROM, RDS | RD | No | No | Survived |
Lalas and Erichsen [6] | 35 | 1990 | F | 2 | PROM | RD | No | No | Good |
Bergman et al. [10] | 29 | 1795 | UK | 5 | RDS, PROM | RD, shock, DIC | Yes | No | Death |
Bergman et al. [10] | 28 | 60 | UK | 20 | IUGR, RDS | RD, shock, DIC | Yes | No | Death |
Bergman et al. [10] | 40 | 3810 | UK | 12 | CHD, PDA | RD, shock, DIC | Yes | No | Death |
Habsah et al. [11] | 26 | 950 | UK | 11 | RDS | RD, shock, DIC | Yes | Yes | Death |
Habsah et al. [11] | 40 | 3300 | UK | 4 | Asphyxia | RD, shock, DIC | Yes | Yes | Death |
Habsah et al. [11] | 32 | 1500 | UK | 3 | RDS | RD, shock, DIC | Yes | Yes | Survived |
Habsah et al. [11] | 40 | 3200 | UK | 5 | VACTERL | RD, shock, DIC | Yes | Yes | Death |
Habsah et al. [11] | 36 | 1670 | UK | 5 | IUGR | RD, shock, DIC | Yes | Yes | Death |
Habsah et al. [11] | 36 | 2000 | UK | 4 | Asphyxia | RD, shock, DIC | Yes | Yes | Death |
Habsah et al. [11] | 26 | 1200 | UK | 5 | RDS | RD, shock, DIC | Yes | Yes | Death |
Cruz et al. [9] | FT | UK | F | 24 | Cardiomyopathy | UK | Yes | No | Death |
Cruz et al. [9] | FT | UK | M | 16 | Coarctation | UK | Yes | No | Survived |
Aly et al. [12] | 30 | 1500 | M | 13 | RDS | RD, Shock | Yes | No | Survived |
Aly et al. [12] | 29 | 1030 | M | 12 | RDS | RD, Shock | Yes | No | Survived |
Aly et al. [12] | 28 | 815 | F | 17 | Pre-NEC | RD, Shock | Yes | No | Survived |
Aly et al. [12] | 26 | 855 | M | 8 | RDS, PDA | RD, Shock | Yes | No | Survived |
Aly et al. [12] | 27 | 1020 | F | 11 | RDS, PDA | RD, Shock | Yes | No | Survived |
AD age at diagnosis, BW birth weight, CF contaminated fluids, CHD congestive heart disease, DIC disseminated intravascular coagulation, F female, FT full term, GA gestational age, IC indwelling catheters, IUGR intrauterine growth retardation, M male, NEC necrotizing enterocolitis, PDA patent ductus arteriosus, PROM prolonged rupture of membrane, RD respiratory distress, RDS respiratory distress syndrome, UK unknown, VACTERL vertebral anomalies, anal atresia, cardiovascular anomalies, tracheoesophageal fistula, esophageal atresia, renal anomalies, limb anomalies